Search results
Is BioNTech SE's (NASDAQ:BNTX) Latest Stock Performance A Reflection Of Its Financial Health?
Simply Wall St. via Yahoo Finance· 2 years agoMost readers would already be aware that BioNTech's (NASDAQ:BNTX) stock increased significantly by...
BioNTech SE Sponsored ADR (BNTX) Outpaces Stock Market Gains: What You Should Know
Zacks via Yahoo Finance· 1 year agoBioNTech SE Sponsored ADR (BNTX) closed the most recent trading day at $131.54, moving +0.59% from...
BioNTech SE's (NASDAQ:BNTX) Stock Has Been Sliding But Fundamentals Look Strong: Is The Market...
Simply Wall St. via Yahoo Finance· 8 months agoWith its stock down 12% over the past month, it is easy to disregard BioNTech (NASDAQ:BNTX)....
Will Weakness in BioNTech SE's (NASDAQ:BNTX) Stock Prove Temporary Given Strong Fundamentals?
Simply Wall St. via Yahoo Finance· 3 months agoWith its stock down 7.5% over the past three months, it is easy to disregard BioNTech (NASDAQ:BNTX)....
Is Weakness In BioNTech SE (NASDAQ:BNTX) Stock A Sign That The Market Could be Wrong Given Its...
Simply Wall St. via Yahoo Finance· 1 year agoBioNTech (NASDAQ:BNTX) has had a rough three months with its share price down 28%. However, a closer...
Does BioNTech SE Sponsored ADR (BNTX) Have the Potential to Rally 48% as Wall Street Analysts...
Zacks via Yahoo Finance· 2 years agoThe average of price targets set by Wall Street analysts indicates a potential upside of 47.9% in...
Investors in BioNTech (NASDAQ:BNTX) have made a enviable return of 356% over the past three years
Simply Wall St. via Yahoo Finance· 1 year agoWhile BioNTech SE (NASDAQ:BNTX) shareholders are probably generally happy, the stock hasn't had...
BioNTech (NASDAQ:BNTX) shareholders have earned a 46% CAGR over the last three years
Simply Wall St. via Yahoo Finance· 1 year agoIt hasn't been the best quarter for BioNTech SE (NASDAQ:BNTX) shareholders, since the share price...
BioNTech SE's (NASDAQ:BNTX) market cap surged US$4.0b last week, private equity firms who have a lot...
Simply Wall St. via Yahoo Finance· 2 years agoIf you want to know who really controls BioNTech SE (NASDAQ:BNTX), then you'll have to look at the...
Insiders own 20% of BioNTech SE (NASDAQ:BNTX) shares but private equity firms control 44% of the...
Simply Wall St. via Yahoo Finance· 9 months agoKey Insights The considerable ownership by private equity firms in BioNTech indicates that they...